News
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...
Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
CBS News - Video on MSN1d
FDA approves first blood test to help screen for Alzheimer's diseaseThe Lumipulse G Plasma Ratio Test offers a new way to detect signs of Alzheimer's disease by identifying plaque proteins in ...
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
Nearly 7 million Americans are living with Alzheimer's disease and this number is projected to rise to nearly 13 million, however, Friday, the U.S. Food and Drug Administration (FDA) cleared ...
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
1d
Medical Device Network on MSNFDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’sThe US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
WASHINGTON (USA TODAY Network) — The Food and Drug Administration said Friday it cleared the first blood test for Alzheimer’s. The Lumipulse blood plasma test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results